Interestingly, a similarly unexplained shorter survival has been reported for female mice in a model for metastatic lung adenocarcinomas based on the combination of a mutant KRas allele and a mutant TP53 allele [48]. The gene discussed is TP53; the disease is lung adenocarcinoma.